372 related articles for article (PubMed ID: 15288472)
1. Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid.
Reif S; Aeed H; Shilo Y; Reich R; Kloog Y; Kweon YO; Bruck R
J Hepatol; 2004 Aug; 41(2):235-41. PubMed ID: 15288472
[TBL] [Abstract][Full Text] [Related]
2. Prevention of liver cirrhosis in rats by curcumin.
Bruck R; Ashkenazi M; Weiss S; Goldiner I; Shapiro H; Aeed H; Genina O; Helpern Z; Pines M
Liver Int; 2007 Apr; 27(3):373-83. PubMed ID: 17355460
[TBL] [Abstract][Full Text] [Related]
3. The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats.
Reif S; Weis B; Aeed H; Gana-Weis M; Zaidel L; Avni Y; Romanelli RG; Pinzani M; Kloog Y; Bruck R
J Hepatol; 1999 Dec; 31(6):1053-61. PubMed ID: 10604579
[TBL] [Abstract][Full Text] [Related]
4. A protective effect of pyrrolidine dithiocarbamate in a rat model of liver cirrhosis.
Bruck R; Schey R; Aeed H; Hochman A; Genina O; Pines M
Liver Int; 2004 Apr; 24(2):169-76. PubMed ID: 15078482
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the Ras oncoprotein reduces proliferation of hepatocytes in vitro and in vivo in rats.
da Silva Morais A; Saliez A; Leclercq I; Horsmans Y; Stärkel P
Clin Sci (Lond); 2008 Jan; 114(1):73-83. PubMed ID: 17678500
[TBL] [Abstract][Full Text] [Related]
6. Action mechanism of Yi Guan Jian Decoction on CCl4 induced cirrhosis in rats.
Mu Y; Liu P; Du G; Du J; Wang G; Long A; Wang L; Li F
J Ethnopharmacol; 2009 Jan; 121(1):35-42. PubMed ID: 18996463
[TBL] [Abstract][Full Text] [Related]
7. Ras inhibition attenuates myocardial ischemia-reperfusion injury.
Pando R; Cheporko Y; Haklai R; Maysel-Auslender S; Keren G; George J; Porat E; Sagie A; Kloog Y; Hochhauser E
Biochem Pharmacol; 2009 May; 77(10):1593-601. PubMed ID: 19426696
[TBL] [Abstract][Full Text] [Related]
8. Beta-carotene attenuates experimentally induced liver cirrhosis in rats.
Wardi J; Reifen R; Aeed H; Zadel L; Avni Y; Bruck R
Isr Med Assoc J; 2001 Feb; 3(2):151-4. PubMed ID: 11344828
[TBL] [Abstract][Full Text] [Related]
9. The Ras inhibitor farnesylthiosalicyclic acid (FTS) prevents nodule formation and development of preneoplastic foci of altered hepatocytes in rats.
Schneider-Merck T; Borbath I; Charette N; De Saeger C; Abarca J; Leclercq I; Horsmans Y; Stärkel P
Eur J Cancer; 2009 Jul; 45(11):2050-60. PubMed ID: 19427195
[TBL] [Abstract][Full Text] [Related]
10. The Ras antagonist farnesylthiosalicylic acid ameliorates experimental myocarditis in the rat.
Pando R; Barshack I; Raz A; Luboshits G; Haklai R; Maysel-Auslender S; Kloog Y; Keren G; George J
Cardiovasc Pathol; 2010; 19(2):94-101. PubMed ID: 19144546
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of intimal thickening in the rat carotid artery injury model by a nontoxic Ras inhibitor.
George J; Sack J; Barshack I; Keren P; Goldberg I; Haklai R; Elad-Sfadia G; Kloog Y; Keren G
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):363-8. PubMed ID: 14670932
[TBL] [Abstract][Full Text] [Related]
12. Induced hypothyroidism accelerates the regression of liver fibrosis in rats.
Bruck R; Weiss S; Traister A; Zvibel I; Aeed H; Halpern Z; Oren R
J Gastroenterol Hepatol; 2007 Dec; 22(12):2189-94. PubMed ID: 18031379
[TBL] [Abstract][Full Text] [Related]
13. Moderately high folic acid supplementation exacerbates experimentally induced liver fibrosis in rats.
Marsillach J; Ferré N; Camps J; Riu F; Rull A; Joven J
Exp Biol Med (Maywood); 2008 Jan; 233(1):38-47. PubMed ID: 18156304
[TBL] [Abstract][Full Text] [Related]
14. [Protein expression profiles in a rat cirrhotic model induced by thioacetamide].
An JH; Seong J; Oh H; Kim W; Han KH; Paik YH
Korean J Hepatol; 2006 Mar; 12(1):93-102. PubMed ID: 16565610
[TBL] [Abstract][Full Text] [Related]
15. Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).
Blum R; Elkon R; Yaari S; Zundelevich A; Jacob-Hirsch J; Rechavi G; Shamir R; Kloog Y
Cancer Res; 2007 Apr; 67(7):3320-8. PubMed ID: 17409441
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte production of modulators of extracellular liver matrix in normal and cirrhotic rat liver.
Garcíade León Mdel C; Montfort I; Tello Montes E; López Vancell R; Olivos García A; González Canto A; Nequiz-Avendaño M; Pérez-Tamayo R
Exp Mol Pathol; 2006 Feb; 80(1):97-108. PubMed ID: 16332368
[TBL] [Abstract][Full Text] [Related]
17. The protective effects of a fermented substance from Saccharomyces cerevisiae on carbon tetrachloride-induced liver damage in rats.
Lai JT; Hsieh WT; Fang HL; Lin WC
Clin Nutr; 2009 Jun; 28(3):338-45. PubMed ID: 19233522
[TBL] [Abstract][Full Text] [Related]
18. Changes in fatty acid composition of plasma, liver microsomes, and erythrocytes in liver cirrhosis induced by oral intake of thioacetamide in rats.
Moreira E; Fontana L; Periago JL; Sanchéz De Medina F; Gil A
Hepatology; 1995 Jan; 21(1):199-206. PubMed ID: 7806155
[TBL] [Abstract][Full Text] [Related]
19. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
[TBL] [Abstract][Full Text] [Related]
20. Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic mice.
Mor A; Kloog Y; Keren G; George J
Eur J Pharmacol; 2009 Aug; 616(1-3):301-5. PubMed ID: 19527709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
